Related Experiment Videos
Maternal morbidity associated with in utero transfer
Summary
In utero transfer can benefit healthy mothers delivering prematurely. However, for mothers with coexisting diseases, this transfer may increase maternal morbidity and risks, necessitating urgent review.
Area of Science:
- Maternal-fetal medicine
- Obstetrics
- Perinatal care
Background:
- Maternal transfer during pregnancy is a critical intervention for optimizing perinatal outcomes.
- Evaluating the maternal risks associated with in utero transfer is essential for informed clinical decision-making.
Purpose of the Study:
- To assess the maternal morbidity linked to in utero transfer.
- To compare outcomes between healthy mothers and those with coexisting conditions.
Main Methods:
- Retrospective analysis of 190 cases over two years at Liverpool Maternity Hospital.
- Categorization of pregnant women into two groups: uncomplicated preterm labor and those with coexisting maternal or fetal factors.
- Interventions included planned delivery and postpartum care, with labor progress and maternal resuscitation as key outcome measures.
Main Results:
- Women transferred without coexisting diseases (124) experienced generally uncomplicated deliveries.
- Mothers with coexisting diseases (66) faced significant maternal morbidity, with 17 requiring extended intensive postpartum monitoring.
- The presence of coexisting conditions substantially increased the risk of adverse maternal outcomes.
Conclusions:
- In utero transfer may offer advantages for very premature births in healthy mothers.
- For mothers with coexisting diseases, the benefits of transfer require urgent re-evaluation due to substantial associated maternal morbidity.
- Transferring high-risk mothers may introduce additional hazards, potentially outweighing benefits.